Pacira BioSciences, Inc.
PCRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001396814
In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Pacira BioSciences, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 282
- +13 vs. Q1 2024
- Shares held
- 51.9M
- +2.79M (+5.7%) vs. Q1 2024
- Total value
- $1.48B
- +$49.4M (+3.4%) vs. Q1 2024
- New holders
- 51
- 106 more added
- Sold out
- 38
- 76 more reduced
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 254 | $1.11B |
| Q1 2026 | 242 | $986.2M |
| Q4 2025 | 261 | $1.22B |
| Q3 2025 | 239 | $1.24B |
| Q2 2025 | 233 | $1.21B |
| Q1 2025 | 235 | $1.26B |
| Q4 2024 | 233 | $940.6M |
| Q3 2024 | 239 | $772.1M |
| Q2 2024 | 282 | $1.48B |
| Q1 2024 | 271 | $1.44B |
| Q4 2023 | 261 | $1.63B |
| Q3 2023 | 262 | $1.46B |
| Q2 2023 | 258 | $1.88B |
| Q1 2023 | 268 | $1.89B |
| Q4 2022 | 273 | $1.87B |
| Q3 2022 | 272 | $2.67B |
| Q2 2022 | 285 | $2.85B |
| Q1 2022 | 301 | $3.79B |
| Q4 2021 | 276 | $3.05B |
| Q3 2021 | 260 | $2.75B |
| Q2 2021 | 261 | $2.99B |
| Q1 2021 | 270 | $3.49B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Pacira BioSciences, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Azzad Asset Management Inc | 0 | $0 | 0.00% | −9,384−100.0% | Sold out |
| Dana Investment Advisors, Inc. | 0 | $0 | 0.00% | −9,345−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −7,395−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −7,172−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −7,151−100.0% | Sold out |
| Stephens Inc | 0 | $0 | 0.00% | −4,940−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −4,892−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −3,987−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,422−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,281−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −2,179−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −2,114−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −463−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −223−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Harbor Investment Advisory, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Elequin Capital LP | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |